Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Nuformix Plc LSE:NFX London Ordinary Share GB00BYW79Y38 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.50p +4.40% 11.875p 6,337,950 16:09:39
Bid Price Offer Price High Price Low Price Open Price
11.75p 12.00p 11.875p 10.75p 11.375p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Nonequity Investment Instruments 0.02 -1.97 -0.49 54.7

Nuformix (NFX) Latest News

More Nuformix News
Nuformix Takeover Rumours

Nuformix (NFX) Share Charts

1 Year Nuformix Chart

1 Year Nuformix Chart

1 Month Nuformix Chart

1 Month Nuformix Chart

Intraday Nuformix Chart

Intraday Nuformix Chart

Nuformix (NFX) Discussions and Chat

Nuformix Forums and Chat

Date Time Title Posts
19/6/201900:28Nuformix plc1,383

Add a New Thread

Nuformix (NFX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:29:5212.00124,30314,916.35O
16:27:4811.97166,07719,887.55O
16:16:1411.90127,85615,214.86O
16:15:0010.50710,36574,588.33O
16:08:0011.88300,00035,625.00O
View all Nuformix trades in real-time

Nuformix (NFX) Top Chat Posts

DateSubject
18/6/2019
09:20
Nuformix Daily Update: Nuformix Plc is listed in the Nonequity Investment Instruments sector of the London Stock Exchange with ticker NFX. The last closing price for Nuformix was 11.38p.
Nuformix Plc has a 4 week average price of 6.30p and a 12 week average price of 2.30p.
The 1 year high share price is 14.25p while the 1 year low share price is currently 1.60p.
There are currently 460,750,000 shares in issue and the average daily traded volume is 4,442,114 shares. The market capitalisation of Nuformix Plc is £54,714,062.50.
11/6/2019
16:25
zagrosfold: No, it's just a superb share that has had a fund selling out due to the great results and trebling of the share price. Should 10 bad from here imo
09/6/2019
21:12
gibso6767: Twitter has a tweet thinking there might be news tomorrow re New Broker , I’m inclined to agree to get others heavily invested, target new potential contracts and keep impetus behind share price
07/6/2019
08:35
calum: Dan mentioned Biogen's Tecfidera in 1 of his podcasts - as a possible comparison - well, last year that had sales of $4.3Billion! I wonder if what a drug like that would do for the share price if NXP002 could target those sorts of sales figures. hxxp://www.pmlive.com/pharma_news/fda_starts_review_of_biogens_tecfidera_follow-up_for_ms_1279596
06/6/2019
07:37
timw3: jeez they still got 22m left to sell... This is gonna hurt the share price unfortunately. can see this heading back to 6p levels by the time they finished
20/5/2019
11:08
leadersoffice: Justin mentioned possibly worth up to 100 million during his podcast based on NX1 & NX2 alone so that could mean if all go well, a share price off 24p ish? am i right?
16/5/2019
09:17
timw3: soup serious question.. if successful in the next few weeks what then for the share price? may have a punt
29/4/2019
08:54
whatsthepoint: Yes happy also I spoke with Dan Gooding a couple weeks ago he said news on new Broker imminent and it would surprise the market as it's the one they want a specialist in this sector. I don't believe the value of the recent news has been reflected in the share price Cannabis medical products will take this to another level. Someone has been cleverly manipulating the price last couple weeks. But it will suddenly pop up to a new trading range. Look at the chart a breakout is next. Imho
09/4/2019
09:57
researchanalyst1: PROFOUNDLY UNDERVALUED... So, has the market got it? Has the market realised that Nuformix is now a first mover in the multibillion dollar, Canadian cannabinoid market? That it stands to receive, shortly, a significant upfront payment running into the millions? And that the payment is likely to dwarf its current market cap? Answer: definitely not. The share price at sub-10p underpins a gross lack of understanding of the transformational nature of the RNS. To this end, take cue from the savvy investors picking-up stock at these obscene levels. A further RNS outlining the significant upfront payment is now imminent. Remember, the projected Canadian consumer market for cannabinoid-based pharmaceuticals in 2020 alone is in excess of £2bn! Nuformix, through Ebers, is now a first mover in this market. Https://www.statista.com/statistics/588853/market-size-of-cannabinoid-pharmaceuticals-in-the-us/ Https://www.voxmarkets.co.uk/articles/nuformix-signs-strategic-agreement-into-canadian-cannabinoid-sector-1996396/
31/1/2018
14:17
soupdragon55: Possible Near Term Share Price Catalyst We expect news on an out-licensing deal quite shortly, which could further validate NFX’s cocrystal technology and the progress made with this to date. In addition, we look for a boost to near and medium term income, which could allow NFX to progress further with the development of its other products.
17/12/2017
19:57
natty27: Simpleton.... very apt name considering! I'm actually invested in nfx you donut!, & it's clear to see if you re-read my post again that I'm not de-ramping a company that I'm invested in. All I was saying is I expect to see a bit of consolidation before moving on to new highs. As you should know... we need to back test our highs before moving on again. I'm sure you would, along with me see the share price on a gradual trend upwards over the next couple of weeks/months/years, rather than sharp increase, followed by sharp declines, as the overused phase goes, nothing goes up in straight lines! Next time you might be less sensitive on trying to pull up a fellow investor in the same company! Not be the can't take any criticism crew, only that everything is amazing & this is going to £1 by the end of the week, boom, to the moon, rockets & fireworks crew!
Nuformix share price data is direct from the London Stock Exchange
Your Recent History
LSE
NFX
Nuformix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 23:42:59